Skip to main content

European Surgery OnlineFirst articles

Open Access 12.04.2024 | main topic

Intraoperative strategies and techniques to achieve surgical radicality in pancreatic cancer

The treatment of pancreatic cancer presents a challenging task in surgical oncology, demanding innovative approaches to achieve radical resection and improve patient outcomes. This article provides an overview of state-of-the-art surgical …

verfasst von:
Thomas Hank, Carl-Stephan Leonhardt, Ulla Klaiber, Oliver Strobel, MD

06.03.2024 | Obituary

Obituary for Univ.-Prof. Dr. med. mult. Jörg Rüdiger Siewert 1940–2024

Aus Sicht seiner Kollegen und Weggefährten war Jörg Rüdiger Siewert – obwohl viele Jahre im Süden Deutschlands wirkend und lebend – ein überzeugter und überzeugender Berliner. Er studierte in Basel und an der FU seiner Geburtsstadt an der er 1965 …

verfasst von:
Univ.-Prof. Dr. Klaus Leonidas Emmanuel

Open Access 09.01.2024 | review

Quality assurance in surgery—a moral obligation

Quality assurance (QA) in surgery is a systematic approach to maintaining and improving the quality of surgical care. It includes clinical guidelines and protocols that standardize surgical procedures (standard operating procedures [SOPs]) and …

verfasst von:
Dietmar Öfner, MD, MSc, FACS

12.12.2023 | original article

MELD-Na score is associated with postoperative complications in non-cirrhotic gastric cancer patients undergoing gastrectomy

Gastrectomy is the surgical procedure often preferred in the curative treatment of gastric cancer, although it may cause significant postoperative complications such as bleeding, ileus, wound infection, intra-abdominal abscess, evisceration …

verfasst von:
Omer Akay, M.D, Mert Guler, M.D, Husnu Sevik, M.D, Ishak Yildiz, M.D, Prof. Mert Mahsuni Sevinc, M.D, Assoc. Prof. Aziz Ari, M.D, Assoc. Prof. Ufuk Oguz Idiz, M.D, Assoc. Prof. Cihad Tatar, M.D.

Open Access 05.10.2023 | main topic

Minimally invasive approaches in pancreatic cancer surgery

This literature review reflects the present evidence on minimally invasive pancreatic surgery, differentiating between distal pancreatic resection and pancreatoduodenectomy for pancreatic cancer. The review analyzed studies comparing minimally …

verfasst von:
Steffen Deichmann, Ulrich Wellner, Louisa Bolm, Kim Honselmann, Rüdiger Braun, Thaer Abdalla, Prof. Dr. med. Dr. h.c. Tobias Keck

Open Access 02.10.2023 | main topic

Personalized treatment in localized pancreatic cancer

The treatment elements used for pancreatic ductal adenocarcinoma (PDAC) include surgical resection, systemic cytotoxic agents, and targeted drugs. For second- and third-line therapies in PDAC, approximately 15% of patients have actionable …

verfasst von:
Prof. Dr. med. John P. Neoptolemos, MA, MB, BChir, MD, FRCS, FMedSci, MAE, Kai Hu, MD, Peter Bailey, PhD, Christoph Springfeld, MD, PhD, Baobao Cai, MD, Yi Miao, MD, Christoph Michalski, MD, Carlos Carvalho, MD, Thilo Hackert, MD, Markus W. Büchler, MD